DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Netupitant is an investigational drug.
There have been 14 clinical trials for Netupitant. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2021.
The most common disease conditions in clinical trials are Vomiting, Nausea, and Neoplasms. The leading clinical trial sponsors are Helsinn Healthcare SA, Consorzio Oncotech, and PSI CRO AG.
There are one hundred and twenty-eight US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Netupitant
|Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)||Helsinn Healthcare SA||Phase 4|
|Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer||Instituto Brasileiro de Controle do Cancer||Phase 2|
|Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin||Helsinn Healthcare SA||Phase 2/Phase 3|
Top disease conditions for Netupitant
Top clinical trial sponsors for Netupitant
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Netupitant||Get Started Free||Crystalline forms of fosnetupitant||Helsinn Healthcare SA (Lugano/Pazzallo, CH)||Get Started Free|
|Netupitant||Get Started Free||Cyclohexyl pyridine derivative||KISSEI PHARMACEUTICAL CO., LTD. (Matsumoto, Nagano, JP)||Get Started Free|
|Netupitant||Get Started Free||.beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof||Quadriga Biosciences, Inc. (Los Altos, CA)||Get Started Free|
|Netupitant||Get Started Free||Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same||STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM)||Get Started Free|
|Netupitant||Get Started Free||Method for cancer cell reprogramming||STC.UNM (Albuquerque, NM)||Get Started Free|
|Netupitant||Get Started Free||Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use||The Trustees of The University of Pennsylvania (Philadelphia, PA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Netupitant||Australia||AU2016335060||2035-10-06||Get Started Free|
|Netupitant||Canada||CA2996466||2035-10-06||Get Started Free|
|Netupitant||China||CN108137626||2035-10-06||Get Started Free|
|Netupitant||European Patent Office||EP3359547||2035-10-06||Get Started Free|
|Netupitant||Japan||JP2018531249||2035-10-06||Get Started Free|
|Netupitant||South Korea||KR20180064453||2035-10-06||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|